Search research articles
Contact Us
Filters
Showing results (121-130 of 174) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
Rachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Haematologica
|
November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
Alexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
American Journal of Hematology
|
March 4, 2021
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m<sup>2</sup> ) in combination with lenalidomide and dexamethasone
Neha Korde, Donna Mastey, Elizabet Tavitian, et al.
British Journal of Haematology
|
July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
Giulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Bone Marrow Transplantation
|
February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
Magdalena Corona, Andrew Ip, Samantha Brown, et al.
Leukemia
|
June 20, 2020
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
Ioannis Politikos, Sean M Devlin, Maria E Arcila, et al.
Blood Advances
|
June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
Gustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Blood Cancer Discovery
|
November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
David J Chung, Gunjan L Shah, Sean M Devlin, et al.
Blood Advances
|
August 25, 2021
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 174) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
Rachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Haematologica
|
November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
Alexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
American Journal of Hematology
|
March 4, 2021
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m<sup>2</sup> ) in combination with lenalidomide and dexamethasone
Neha Korde, Donna Mastey, Elizabet Tavitian, et al.
British Journal of Haematology
|
July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
Giulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Bone Marrow Transplantation
|
February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
Magdalena Corona, Andrew Ip, Samantha Brown, et al.
Leukemia
|
June 20, 2020
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
Ioannis Politikos, Sean M Devlin, Maria E Arcila, et al.
Blood Advances
|
June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
Gustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Blood Cancer Discovery
|
November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
David J Chung, Gunjan L Shah, Sean M Devlin, et al.
Blood Advances
|
August 25, 2021
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, et al.
Page
of 18